Publications

Phase II open-label randomized multi-centre study of neoadjuvant olaparib in patients (pts) with platinum sensitive (PS) relapsed high grade serous ovarian cancer (OC): The NEO trial.

Authors: Y Kanjanapan, S Lheureux, T May, MK Wilson, M Bernardini, PA Shaw, I Vergot...

E-pub date: 20 May 2017

Journal name: Journal of Clinical Oncology

A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA.

Authors: J Wan, S Murphy, DG Gale, JA Morris, F Mouliere, A Gill, F Marass, K Heider...

E-pub date: 20 May 2017

Journal name: Journal of Clinical Oncology

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer.

Authors: CV Fribbens, I Garcia-Murillas, M Beaney, S Hrebien, K Howarth, M Epstein, ...

E-pub date: 20 May 2017

Journal name: Journal of Clinical Oncology

Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors

Authors: A Henssen, R Koche, J Zhuang, E Jiang, C Reed, A Eisenberg, E Still, I MacA...

E-pub date: 15 May 2017

Journal name: Nature Genetics

Site-Selective Modification of Proteins with Oxetanes.

Authors: O Boutureira, N Martínez-Sáez, KM Brindle, AA Neves, F Corzana, GJL Berna...

E-pub date: 11 May 2017

Journal name: Chemistry

Frontispiece: Site‐Selective Modification of Proteins with Oxetanes

Authors: O Boutureira, N Martínez‐Sáez, KM Brindle, AA Neves, F Corzana, GJL Ber...

E-pub date: 11 May 2017

Journal name: Chemistry - A European Journal

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Authors: T Goranova, D Ennis, AM Piskorz, G Macintyre, LA Lewsley, J Stobo, C Wilson...

E-pub date: 9 May 2017

Journal name: Br J Cancer

Multi-site Neurogenin3 Phosphorylation Controls Pancreatic Endocrine Differentiation.

Authors: R Azzarelli, C Hurley, MK Sznurkowska, S Rulands, L Hardwick, I Gamper, F A...

E-pub date: 8 May 2017

Journal name: Dev Cell

Filters

Research Groups

Core Facilities

Start date

End date

Phase II open-label randomized multi-centre study of neoadjuvant olaparib in patients (pts) with platinum sensitive (PS) relapsed high grade serous ovarian cancer (OC): The NEO trial.

A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA.

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer.

Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors

Site-Selective Modification of Proteins with Oxetanes.

Frontispiece: Site‐Selective Modification of Proteins with Oxetanes

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Multi-site Neurogenin3 Phosphorylation Controls Pancreatic Endocrine Differentiation.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Phase II open-label randomized multi-centre study of neoadjuvant olaparib in patients (pts) with platinum sensitive (PS) relapsed high grade serous ovarian cancer (OC): The NEO trial.

A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA.

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer.

Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors

Site-Selective Modification of Proteins with Oxetanes.

Frontispiece: Site‐Selective Modification of Proteins with Oxetanes

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Multi-site Neurogenin3 Phosphorylation Controls Pancreatic Endocrine Differentiation.